ArticleStem cell research & therapy2023

Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity.

Yifan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.